Zahedan Journal of Research in Medical Sciences

Published by: Neoscriber Demo Publisher

Molecular Cloning of Leishmania major gp63 Gene in BALB/c Mouse CT26 Cell Line

Hossein Rezvan 1 , *
Author Information
1 Department of Laboratory Sciences, Faculty of Paraveterinary Sciences, Bu-Ali Sina University, Hamadan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: May 28, 2015, 17 (5)
  • Published Online: May 31, 2015
  • Article Type: Research Article
  • Received: January 16, 2014
  • Accepted: April 5, 2014
  • DOI: 10.17795/zjrms958

To Cite: Rezvan H. Molecular Cloning of Leishmania major gp63 Gene in BALB/c Mouse CT26 Cell Line, Zahedan J Res Med Sci. 2015 ; 17(5):-. doi: 10.17795/zjrms958.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Royer MA, Crowe CO. American cutaneous leishmaniasis. Arch Pathol Lab Med. 2002; 126(4): 471-3[DOI][PubMed]
  • 2. TDR/WHO . Leishmaniasis. 2012;
  • 3. Griekspoor A, Sondorp E, Vos T. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. Health Policy Plan. 1999; 14(1): 70-6[PubMed]
  • 4. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004; 27(5): 305-18[DOI][PubMed]
  • 5. Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol. 1995; 21(2): 123-52[DOI][PubMed]
  • 6. Soto J, Rojas E, Guzman M, Verduguez A, Nena W, Maldonado M, et al. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. Clin Infect Dis. 2013; 56(9): 1255-60[DOI][PubMed]
  • 7. Zucca M, Scutera S, Savoia D. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases. Curr Med Chem. 2013; 20(4): 502-26[PubMed]
  • 8. Ali SA, Rezvan H, McArdle SE, Khodadadi A, Asteal FA, Rees RC. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. Parasite Immunol. 2009; 31(7): 373-83[DOI][PubMed]
  • 9. Maroof A, Brown N, Smith B, Hodgkinson MR, Maxwell A, Losch FO, et al. Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis. 2012; 205(5): 853-63[DOI][PubMed]
  • 10. Kedzierska K, Curtis JM, Valkenburg SA, Hatton LA, Kiu H, Doherty PC, et al. Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PLoS One. 2012; 7(3)[DOI][PubMed]
  • 11. Mayrink W, Mendonca-Mendes A, de Paula JC, Siqueira LM, Marrocos Sde R, Dias ES, et al. Cluster randomised trial to evaluate the effectiveness of a vaccine against cutaneous leishmaniasis in the Caratinga microregion, south-east Brazil. Trans R Soc Trop Med Hyg. 2013; 107(4): 212-9[DOI][PubMed]
  • 12. Armijos RX, Weigel MM, Aviles H, Maldonado R, Racines J. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. J Infect Dis. 1998; 177(5): 1352-7[PubMed]
  • 13. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res. 2006; 123(3): 423-38[PubMed]
  • 14. Joshi PB, Sacks DL, Modi G, McMaster WR. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol Microbiol. 1998; 27(3): 519-30[PubMed]
  • 15. Chaudhuri G, Chaudhuri M, Pan A, Chang KP. Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J Biol Chem. 1989; 264(13): 7483-9[PubMed]
  • 16. Seay MB, Heard PL, Chaudhuri G. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect Immun. 1996; 64(12): 5129-37[PubMed]
  • 17. Arora SK, Pal NS, Mujtaba S. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines. Exp Parasitol. 2005; 109(3): 163-70[DOI][PubMed]
  • 18. Soudi S, Hosseini AZ, Hashemi SM. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice. Parasite Immunol. 2011; 33(10): 561-71[PubMed]
  • 19. Ravindran R, Bhowmick S, Das A, Ali N. Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis. BMC Microbiol. 2010; 10: 181[DOI][PubMed]
  • 20. Farajnia S, Rahbarnia L, Maleki Zanjani B, Alimohammadian MH, Abdoli Oskoee S, Beh-Pajooh A, et al. molecular cloning and characterization of P4 nuclease from leishmania infantum. Enzyme Res. 2011; 2011: 970983[DOI][PubMed]
  • 21. Rasouli M, Zavaran Hoseini A, Kazemi B, Alborzi A, Kiany S. Expression of recombinant heat-shock protein 70 of MCAN/IR/96/LON-49, a tool for diagnosis and future vaccine research. Iran J Immunol. 2009; 6(2): 75-86[PubMed]
  • 22. Larreta R, Soto M, Alonso C, Requena JM. Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity. Exp Parasitol. 2000; 96(2): 108-15[PubMed]
  • 23. Cheng J, Zhong Y, Liu Y, Yang J. Cloning and sequence analysis of an amastin coding gene from Leishmania major Abdou. Chin Med J (Engl). 1999; 112(8): 698-700[PubMed]
  • 24. Chen J, Si CW, Wang QH, Liu Y, Zhong YW, Yang JZ, et al. [Cloning and sequence analysis of a gene encoding amastin from Leishmania major]. Chinese. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000; 18(1): 30-2[PubMed]
  • 25. Li JF, Chen JP, Tian Y, Yang ZW, Ma Y, Hu XS. [Cloning of avastin gene of leishmania donovani isolates from Sichuan Province and its expression in eucaryotic system]. Chinese. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007; 25(2): 124-8[PubMed]
  • 26. Bhardwaj S, Vasishta RK, Arora SK. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis. Exp Parasitol. 2009; 121(1): 29-37[DOI][PubMed]
  • 27. Mazumder S, Maji M, Ali N. Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection. PLoS Negl Trop Dis. 2011; 5(12)[DOI][PubMed]
  • 28. Mazumder S, Maji M, Das A, Ali N. Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice. PLoS One. 2011; 6(2)[DOI][PubMed]
  • 29. Rezvan H, Rees R, Ali S. Immunogenicity of MHC class I peptides derived from leishmania mexicana Gp63 in HLA-A2.1 transgenic (HHDII) and BALB/C mouse models. Iran J Parasitol. 2012; 7(4): 27-40[PubMed]
  • 30. Rezvan H. Immunogenicity of HLA-DR1 restricted peptides derived from Leishmania major gp63 using FVB/N-DR1 transgenic mouse model. Iran J Parasitol. 2013; 8(2): 273-9[PubMed]
  • 31. Rezvan H, Rees R, Ali S. Leishmania mexicana Gp63 cDNA using gne Gun induced higher immunity to L. mexicana infection compared to soluble Leishmania antigen in BALB/C. Iran J Parasitol. 2011; 6(4): 60-75[PubMed]
  • 32. Nagill R, Kaur S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol. 2011; 11(10): 1464-88[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments